Jaguar Health (JAGX) Cash & Current Investments (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Cash & Current Investments data on file, last reported at $10.1 million in Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $10.1 million, up 76.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.1 million (up 76.87% YoY), and the FY2025 annual result was $1.3 million, down 83.88% from the prior year.
• Cash & Current Investments advanced to $10.1 million in Q1 2026 per JAGX's latest filing, from $1.3 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $17.5 million in Q1 2022 and troughed at $1.3 million in Q4 2025.
• A 5-year average of $8.6 million and a median of $8.6 million in 2023 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments jumped 311.31% in 2024, then sank 86.25% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $5.5 million in 2022, then gained by 18.28% to $6.5 million in 2023, then increased by 23.7% to $8.0 million in 2024, then tumbled by 83.88% to $1.3 million in 2025, then jumped by 680.16% to $10.1 million in 2026.
• Business Quant data shows JAGX's Cash & Current Investments at $10.1 million in Q1 2026, $1.3 million in Q4 2025, and $3.5 million in Q3 2025.